Efficacy Assessments Clause Samples

The Efficacy Assessments clause defines the procedures and criteria for evaluating whether a product, treatment, or intervention achieves its intended results. Typically, this clause outlines the specific methods, timing, and metrics to be used in measuring efficacy, such as clinical endpoints in a medical trial or performance benchmarks in a technology agreement. By establishing clear standards and processes for assessment, this clause ensures objective measurement of outcomes and helps determine if contractual obligations related to efficacy are met.
Efficacy Assessments. The primary efficacy endpoint and many of the secondary and exploratory efficacy endpoints in this study are derived from clinician-administered assessments which must be administered by qualified and trained individuals at each clinical site. Study specific training will be required before staff is allowed to administer these scales. In an attempt to minimize variability in responses of a given patient over time, it is important that the same rater administer the scales to a given patient throughout the study unless absolutely unavoidable due to the rater’s absence from the clinic. It is also important that the assessments, including those that are patient-completed, be conducted in the specified order, according to specific instructions, and in a setting where the patient has minimal distractions, appropriate privacy, and sufficient time to complete them.
View SourceView Similar (2)
Efficacy Assessments. All assessments will be conducted according to the Schedule of Assessments (Table 2). Study assessments that involve participant interviews, including the HAM-D and SCID-5-CT, may be audiotaped for independent quality control purposes. All assessments must be conducted by raters that have been trained and certified to conduct assessments in this study. 11.1.1. ▇▇▇▇▇▇▇▇ Rating Scale for Depression (HAM-D)
View Source
Efficacy Assessments. Many of the secondary and exploratory efficacy endpoints in this study are derived from patientive patient-completed assessments. Therefore, it is critical that these assessments are conducted in the specified order, according to specific instructions, and in a setting where the patient has minimal distractions and sufficient time to complete them. After completion of these assessments, the study coordinator should review the responses for completeness with the patient.
View Source
Efficacy Assessments. 7.3.1. Non-Hodgkin’s Lymphoma and Advanced Solid Malignancy Assessments
View Source
Efficacy Assessments. 8.2.1. Hidradenitis Suppurativa Clinical Response (HiSCR)
View Source
Efficacy Assessments. Efficacy assessments will be collected as outlined in the Schedule of Assessments (Section 1.3).
View Source
Efficacy Assessments. No efficacy assessments will be obtained during this study.
View Source
Efficacy Assessments 
View Source

Related to Efficacy Assessments

  • Risk Assessments a. Risk Assessment - DST shall, at least annually, perform risk assessments that are designed to identify material threats (both internal and external) against Fund Data, the likelihood of those threats Schedule 10.2 p.2 occurring and the impact of those threats upon DST organization to evaluate and analyze the appropriate level of information security safeguards (“Risk Assessments”). b. Risk Mitigation - DST shall use commercially reasonable efforts to manage, control and remediate threats identified in the Risk Assessments that it believes are likely to result in material unauthorized access, copying, use, processing, disclosure, alteration, transfer, loss or destruction of Fund Data, consistent with the Objective, and commensurate with the sensitivity of the Fund Data and the complexity and scope of the activities of DST pursuant to the Agreement. c. Security Controls Testing - DST shall, on approximately an annual basis, engage an independent external party to conduct a review (including information security) of DST’s systems that are related to the provision of services. DST shall have a process to review and evaluate high risk findings resulting from this testing.

  • Security Assessments Upon advance written notice by the JBE, Contractor agrees that the JBE shall have reasonable access to Contractor’s operational documentation, records, logs, and databases that relate to data security and the Contractor’s Information Security Program. Upon the JBE’s request, Contractor shall, at its expense, perform, or cause to have performed an assessment of Contractor’s compliance with its privacy and data security obligations. Contractor shall provide to the JBE the results, including any findings and recommendations made by Contractor’s assessors, of such assessment, and, at its expense, take any corrective actions.

  • Diagnostic Assessment 6.3.1 Boards shall provide a list of pre-approved assessment tools consistent with their Board improvement plan for student achievement and which is compliant with Ministry of Education PPM (PPM 155: Diagnostic Assessment in Support of Student Learning, date of issue January 7, 2013). 6.3.2 Teachers shall use their professional judgment to determine which assessment and/or evaluation tool(s) from the Board list of preapproved assessment tools is applicable, for which student(s), as well as the frequency and timing of the tool. In order to inform their instruction, teachers must utilize diagnostic assessment during the school year.

  • Loss Assessment We will pay up to $1000 for your share of loss assessment charged during the policy period against you by a corporation or as- sociation of property owners, when the assess- ment is made as a result of:

  • Ergonomic Assessments ‌ At the request of the employee, the Employer will ensure that an ergonomic assessment of the employee’s workstation is completed. Solutions to identified issues will be implemented within available resources.